#USA #Natus Medical #Middleton #autoSCORE #BRAIN QUICK

Natus Medical's New Venture in Neurodiagnostics

Natus Medical Incorporated is taking a significant step in the field of neurology by integrating the autoSCORE™ analysis tool into the latest update of their BRAIN QUICK® Software. This strategic move aims to broaden access to advanced, AI-supported EEG interpretation technology—especially within European and international markets. Originally launched in the United States in August 2024 with the Natus NeuroWorks® EEG Software, the autoSCORE tool has now been certified with the CE mark, paving the way for its international rollout.

Enhancing Clinical Efficiency

The addition of autoSCORE to BRAIN QUICK reflects Natus's commitment to transforming neurodiagnostics. Cristiano Rizzo, General Manager for Natus’s EMEA/APAC regions, emphasized that this development represents a remarkable advancement in digital neurodiagnostics. The aim is to supply neurologists with state-of-the-art technology that complements their existing expertise, ensuring that each patient can receive timely and insightful data without compromising the quality of clinical assessments.

The Impact of Artificial Intelligence

According to Professor Oriano Mecarelli from Sapienza University of Rome’s Department of Neurosciences, the potential of artificial intelligence in transforming EEG practices is akin to how digital EEG revolutionized neurophysiology years ago. Tools like autoSCORE have the capacity to broaden access to specialized knowledge, optimize workflow, and assist clinicians even in complex and fast-paced environments.

Streamlining EEG Analysis

The autoSCORE AI tool is not only focused on speeding up the process; it's designed to take off some of the pressure on clinical personnel by providing automated analysis. This feature utilizes a deep-learning model that has been trained on 30,000 expertly labeled EEG recordings. Early adopters of the tool appreciate its ability to enhance confidence beyond traditional spike and seizure detection, allowing for comprehensive assessments of various clinically significant abnormalities.

Furthermore, the insights it provides can inform healthcare providers whether an EEG study is normal or abnormal, which is crucial for effective patient management. The closed AI model ensures consistency and security, positioning autoSCORE as a reliable partner in clinical settings.

Positive Feedback from Clinicians

Clinicians utilizing the updated version of BRAIN QUICK Software have welcomed its reliability in high-complexity and high-volume contexts, such as presurgical evaluations. They have described its recording capabilities as “impeccable,” which enhances the overall patient care experience. The feedback indicates that the integration of autoSCORE into BRAIN QUICK has successfully addressed the need for high-quality EEG review and reporting while supporting clinicians in their demanding roles.

A Commitment to Innovation

With both NeuroWorks and BRAIN QUICK Software now equipped with autoSCORE, Natus is laying a robust foundation for ongoing advancements in neuroscience. The company is dedicated to continuing to provide unparalleled innovations in neurodiagnostics. Its strategic focus lies in empowering healthcare professionals with the tools they need to elevate patient outcomes and enhance their quality of life.

About Natus Medical

Natus is a globally recognized leader in providing solutions aimed at diagnosing and treating conditions affecting the brain and neural pathways. With a portfolio that includes exemplary service, field support, and educational offerings, Natus aims to enhance the standard of care that clinicians can provide. For further information about Natus and its offerings, visit natus.com/neuro.